Development and evaluation of a breast cancer prevention decision aid for higher-risk women
- PMID: 12603624
- PMCID: PMC5060163
- DOI: 10.1046/j.1369-6513.2003.00195.x
Development and evaluation of a breast cancer prevention decision aid for higher-risk women
Abstract
Objective: To develop and evaluate the effectiveness of a breast cancer prevention decision aid for women aged 50 and older at higher risk of breast cancer.
Design: Pre-test-post-test study using decision aid alone and in combination with counselling.
Setting: Breast Cancer Risk Assessment Clinic.
Participants: Twenty-seven women aged 50-69 with 1.66% or higher 5-year risk of breast cancer.
Intervention: Self-administered breast cancer prevention decision aid.
Main outcome measures: Acceptability; decisional conflict; knowledge; realistic expectations; choice predisposition; intention to improve life-style practices; psychological distress; and satisfaction with preparation for consultation.
Results: The decision aid alone, or in combination with counselling, decreased some dimensions of decisional conflict, increased knowledge (P < 0.01), and created more realistic expectations (P < 0.01). The aid in combination with counselling, significantly reduced decisional conflict (P < 0.01) and psychological distress (P < 0.02), helped the uncertain become certain (P < 0.02), and increased intentions to adopt healthier life-style practices (P < 0.03). Women rated the aid as acceptable, and both women and practitioners were satisfied with the effect it had on the counselling session.
Conclusion: The decision aid shows promise as a useful decision support tool. Further research should compare the effect of the decision aid in combination with counselling to counselling alone.
Figures
References
-
- Stacey D, DeGrasse C, Johnston L. Addressing the support needs of women at high risk for breast cancer: evidence‐based care by advanced practice nurses. Oncology Nursing Forum, 2002; 29: E77–E84. Retrieved 12 August 2002 from http://www.ons.org/xp6/ONS/Library.xml/ONS_Publications.xml/ONF.xml. - PubMed
-
- Fisher B, Joseph P, Costantino D et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P‐1 study. Journal of the National Cancer Institute, 1998; 90: 1371–1388. - PubMed
-
- Powles T, Eeles R, Ashley S et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial. Lancet, 1998; 352: 98–101. - PubMed
-
- Veronesi V, Maisonneuve P, Costa A et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet, 1998; 352: 93–97. - PubMed
-
- Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies : Tamoxifen and Raloxifene. Journal of Clinical Oncology, 1999; 17: 1939–1955. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical